![There isnât just one face to breast cancer](https://www.cdc.gov/cancer/breast/young_women/bringyourbrave/flexslider/images/Charity_BYB_925X350.jpg)
![](https://phgkb.cdc.gov/PHGKB/images/Whats_new.jpg)
Last Posted: Jan 03, 2019
- BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
Cline Melissa S et al. PLoS genetics 2018 Dec 14(12) e1007752 - Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
Machirori Mavis et al. European journal of medical genetics 2018 Dec - Hereditary breast cancer; Genetic penetrance and current status with BRCA.
Mahdavi Morteza et al. Journal of cellular physiology 2018 Dec - Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil.
Cipriano Nilson Moreira et al. Breast cancer (Tokyo, Japan) 2018 Dec - Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?
Nicolas Emanuel et al. Cancers 2018 Dec 10(12) - A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer.
Velázquez Carolina et al. Breast (Edinburgh, Scotland) 2018 Nov 4391-96 - Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers A Complex Discussion
S Domchek, JAMA< December 6, 2018 - A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults
M. Murray and the Genomics and Population Health Action Collaborative, National Academies of Medicine, December 3, 2018 - Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
Laitman Yael et al. Cancer 2018 Nov - Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey Melissa K et al. Cancer 2018 Nov
No hay comentarios:
Publicar un comentario